RxDoctor Payments Data

Christina Moore, MD

Interventional Pain Medicine · Milwaukee, WINPI 1962848945

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by SPR Therapeutics, Inc at 52.7% of the total. 2025 is the largest year on record at $19,096, more than ten times the $136 reported in 2019. Among interventional pain medicine clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,266in general payments, 2019–2025

Across 97 payments — averaging $270.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$14K
  • Medtronic$10K
  • Spinal Simplicity, LLC$1K
  • Nevro Corp.$497
  • Abbott$415
  • Boston Scientific$330
  • plus $484 from 5 others

What the payments were for

  • Consulting fees$11,00042%
  • Speaking & faculty fees$7,89030%
  • Travel & lodging$3,08912%
  • Food & beverage$4,28716%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,266 in reported general payments places this provider in the 95th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$101,019
Medicare patients
249
Services billed
5,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine100$5,582
Diclofenac Sodium56$4,485
Gabapentin215$3,213
Pregabalin132$2,465
Duloxetine Hcl49$736
Tizanidine Hcl50$643
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$219
Baclofen19$182
Cyclobenzaprine Hcl17$122
Cephalexin33$50
Diazepam17$19

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →